Komori
Mitsui DM Sugar (2109) · FactAnnual R&D Expenditure of ¥968 Million

¥753 million in R&D activity expenses for the cumulative third quarter

First written in FY2018-Q3. . Latest entry: FY2026.

27entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q3 – FY20262018: 320182019: 420192020: 420202021: 320212022: 320222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 206 companies write about · 0 as a headwind · 219 as a tailwind

89 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 221 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Annual R&D Expenditure of ¥968 MillionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥968 million.」

    Annual R&D expenditure increased from ¥883 million in the previous fiscal year to ¥968 million.
  2. FY2026-H1Interim R&D expenditure: ¥489 millionAnnual report

    「The Group's R&D expenditure for the interim consolidated accounting period was ¥489 million.」

    ¥489 million was disclosed as the Group's R&D expenditure for the interim consolidated accounting period. It stated that there had been no material changes in its R&D activities.
  3. FY2025Annual R&D expenditure: ¥883 millionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥883 million.」

    Annual R&D expenditure increased from ¥759 million in the previous fiscal year to ¥883 million.
  4. FY2025-H1Interim R&D expenditure: ¥437 millionAnnual report

    「The Group's R&D expenditure for the interim consolidated accounting period was ¥437 million.」

    ¥437 million was disclosed as the Group's R&D expenditure for the interim consolidated accounting period, and it stated that there had been no material changes in its R&D activities.
  5. FY2024Annual R&D expenditure: ¥759 millionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥759 million.」

    Annual R&D expenditure changed from ¥882 million in the previous fiscal year to ¥759 million.
  6. FY2024-Q3Third-quarter R&D expenditure: ¥581 millionAnnual report

    「The Group's R&D expenditure for the third-quarter consolidated cumulative period was ¥581 million.」

    ¥581 million was disclosed as the Group's R&D expenditure for the third-quarter consolidated cumulative period, and it stated that there had been no material changes in its R&D activities.
  7. FY2024-Q2Second-quarter R&D expenditure: ¥394 millionAnnual report

    「The Group's R&D expenditure for the second-quarter consolidated cumulative period was ¥394 million.」

    ¥394 million was disclosed as the Group's R&D expenditure for the second-quarter consolidated cumulative period, and it stated that there had been no material changes in its R&D activities.
  8. FY2024-Q1First-quarter R&D expenditure: ¥205 millionAnnual report

    「The Group's R&D expenditure for the first-quarter consolidated cumulative period was ¥205 million.」

    ¥205 million was disclosed as the Group's R&D expenditure for the first-quarter consolidated cumulative period, and it stated that there had been no material changes in its R&D activities.
  9. FY2023Annual R&D expenditure: ¥882 millionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥882 million.」

    ¥882 million was disclosed as the Group's annual R&D expenditure.
  10. FY2023-Q3Third-quarter R&D expenditure: ¥675 millionAnnual report

    「The Group's R&D expenditure for the third-quarter consolidated cumulative period was ¥675 million.」

    ¥675 million was disclosed as the Group's R&D expenditure for the third-quarter consolidated cumulative period, and it stated that there had been no material changes in its R&D activities.
  11. FY2023-Q2Second-quarter R&D expenditure: ¥461 millionAnnual report

    「The Group's R&D expenditure for the second-quarter consolidated cumulative period was ¥461 million.」

    ¥461 million was disclosed as the Group's R&D expenditure for the second-quarter consolidated cumulative period, and it stated that there had been no material changes in its R&D activities.
  12. FY2022Annual R&D expenditure: ¥1,001 millionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥1,001 million.」

    ¥1,001 million was disclosed as the Group's total R&D expenditure for FY2022.
  13. FY2022-Q3Third-quarter R&D expenditure: ¥786 millionAnnual report

    「The Group's R&D expenditure for the third-quarter consolidated cumulative period was ¥786 million.」

    ¥786 million was disclosed as the Group's R&D expenditure for the third-quarter consolidated cumulative period. It stated that there had been no material changes in its R&D activities.
  14. FY2022-Q2Second-quarter R&D expenditure: ¥559 millionAnnual report

    「The Group's R&D expenditure for the second-quarter consolidated cumulative period was ¥559 million.」

    ¥559 million was disclosed as the Group's R&D expenditure for the second-quarter consolidated cumulative period. It stated that there had been no material changes in its R&D activities.
  15. FY2022-Q1First-quarter R&D expenditure: ¥298 millionAnnual report

    「The Group's R&D expenditure for the first-quarter consolidated cumulative period was ¥298 million.」

    ¥298 million was disclosed as the Group's R&D expenditure for the first-quarter consolidated cumulative period. It stated that there had been no material changes in its R&D activities.
  16. FY2021-Q3Third-quarter R&D expenditure: ¥734 millionAnnual report

    「The Group's R&D expenditure for the third-quarter consolidated cumulative period was ¥734 million.」

    ¥734 million was disclosed as the Group's R&D expenditure for the third-quarter consolidated cumulative period. It stated that there had been no material changes in its R&D activities.
  17. FY2021-Q2Second-quarter R&D expenditure: ¥461 millionAnnual report

    「The Group's R&D expenditure for the second-quarter consolidated cumulative period was ¥461 million.」

    ¥461 million was disclosed as the Group's R&D expenditure for the second-quarter consolidated cumulative period. It stated that there had been no material changes in its R&D activities.
  18. FY2021-Q1First-quarter R&D expenditure: ¥199 millionAnnual report

    「The Group's R&D expenditure for the first-quarter consolidated cumulative period was ¥199 million.」

    ¥199 million was disclosed as the Group's R&D expenditure for the first-quarter consolidated cumulative period. It stated that there had been no material changes in its R&D activities.
  19. FY2020Annual R&D expenditure: ¥1,093 millionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥1,093 million.」

    ¥1,093 million was disclosed as total R&D expenditure for FY2020.
  20. FY2020-Q3Third-quarter R&D expenditure: ¥797 millionAnnual report

    「The Group's R&D expenditure for the third-quarter consolidated cumulative period was ¥797 million.」

    ¥797 million was disclosed as the Group's R&D expenditure for the third-quarter consolidated cumulative period.
  21. FY2020-Q2Second-quarter R&D expenditure: ¥550 millionAnnual report

    「The Group's R&D expenditure for the second-quarter consolidated cumulative period was ¥550 million.」

    ¥550 million was disclosed as the Group's R&D expenditure for the second-quarter consolidated cumulative period.
  22. FY2020-Q1First-quarter R&D expenditure: ¥272 millionAnnual report

    「The Group's R&D expenditure for the first-quarter consolidated cumulative period was ¥272 million.」

    ¥272 million was disclosed as the Group's R&D expenditure for the first quarter of FY2020.
  23. FY2019Annual R&D expenditure: ¥1,092 millionAnnual report

    「The total R&D expenditure for the consolidated fiscal year was ¥1,092 million.」

    ¥1,092 million was disclosed as the Group's total R&D expenditure for FY2019.
  24. FY2019-Q3Third-quarter R&D expenditure: ¥834 millionAnnual report

    「The Group's R&D expenditure for the third-quarter consolidated cumulative period was ¥834 million.」

    ¥834 million was disclosed as the Group's R&D expenditure for the third-quarter consolidated cumulative period.
  25. FY2019-Q2First-quarter R&D expenditure: ¥542 millionAnnual report

    「The Group's R&D expenditure for the second-quarter consolidated cumulative period was ¥542 million.」

    ¥542 million was disclosed as the Group's R&D expenditure for the second-quarter consolidated cumulative period.
  26. FY2019-Q1First-quarter research and development expenses: ¥294 millionAnnual report

    「The amount spent on research and development activities across the Group during the cumulative first quarter of the current consolidated fiscal year was ¥294 million.」

    ¥294 million was disclosed as the Group's R&D expenditure for the first-quarter consolidated cumulative period.
  27. FY2018-Q3First statedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative third quarter of the current consolidated fiscal year was ¥753 million.」

    The Group disclosed ¥753 million in research and development expenses for the cumulative third quarter of the current consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Mitsui DM Sugar's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.